Candel Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
11.60
|
|
Average Rating
|
4.25
|
|
# Strong Buys
|
1
|
|
# Buys
|
3
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.33
|
0.00
|
0.33
|
100.00%
|
|
2022-09-30
|
-0.35
|
-0.30
|
0.05
|
14.29%
|
|
2022-06-30
|
-0.41
|
-0.32
|
0.09
|
21.95%
|
|
2022-03-31
|
-0.31
|
-0.32
|
-0.01
|
-3.23%
|
|
2021-12-31
|
-0.32
|
0.31
|
0.63
|
196.88%
|
|
2021-09-30
|
-0.29
|
-0.26
|
0.03
|
10.34%
|
|
2021-06-30
|
-0.12
|
-0.31
|
-0.19
|
-158.33%
|
|
2021-03-31
|
0.00
|
-0.35
|
-0.35
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.94
|
|
2021-12-31
|
-0.61
|